Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lofts

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
British Journal of Cancer|June 12, 2003
Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancerA Saini, A R Norman, D Cunningham, et al.
British Journal of Cancer|December 24, 2010
A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findingsM Okera, S Chan, U Dernede, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2005
A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancerI Chau, A R Norman, D Cunningham, et al.
Gynecologic Oncology|April 29, 2006
Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First StudyC B Steer, K Chrystal, K A Cheong, et al.
Acta Oncologica (Stockholm, Sweden)|October 24, 2001
Issues of normal tissue toxicity in patient and animal studies--effect of carbogen breathing in rats after 5-fluorouracil treatmentJ R Griffiths, D J McIntyre, F A Howe, et al.
British Journal of Cancer|August 13, 2009
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 StudyJ W Valle, H Wasan, P Johnson, et al.
British Journal of Cancer|July 7, 2012
Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II studyA Roy, D Cunningham, R Hawkins, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
British Journal of Cancer|June 12, 2003
Twelve weeks of protracted venous infusion of fluorouracil (5-FU) is as effective as 6 months of bolus 5-FU and folinic acid as adjuvant treatment in colorectal cancerA Saini, A R Norman, D Cunningham, et al.
British Journal of Cancer|December 24, 2010
A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findingsM Okera, S Chan, U Dernede, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2005
A randomised comparison between 6 months of bolus fluorouracil/leucovorin and 12 weeks of protracted venous infusion fluorouracil as adjuvant treatment in colorectal cancerI Chau, A R Norman, D Cunningham, et al.
Gynecologic Oncology|April 29, 2006
Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First StudyC B Steer, K Chrystal, K A Cheong, et al.
Acta Oncologica (Stockholm, Sweden)|October 24, 2001
Issues of normal tissue toxicity in patient and animal studies--effect of carbogen breathing in rats after 5-fluorouracil treatmentJ R Griffiths, D J McIntyre, F A Howe, et al.
British Journal of Cancer|August 13, 2009
Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 StudyJ W Valle, H Wasan, P Johnson, et al.
British Journal of Cancer|July 7, 2012
Docetaxel combined with irinotecan or 5-fluorouracil in patients with advanced oesophago-gastric cancer: a randomised phase II studyA Roy, D Cunningham, R Hawkins, et al.
Pageof 2